RYTM
Rhythm Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$87.38
-3.77 ▼ -4.14%
🌙 3월 13일 4:54 PM ET (한국 3/14 05:54)
$87.81
+0.43 ▲ +0.49%
| Index | RUT | P/E | - | EPS (ttm) | -3.11 | Insider Own | 6.75% | Shs Outstand | 0.07B | Perf Week | -6.57% |
| Market Cap | 5.97B | Forward P/E | - | EPS next Y | 92.02% | Insider Trans | -1.79% | Shs Float | 0.06B | Perf Month | -11.26% |
| Enterprise Value | 5.82B | PEG | - | EPS next Q | -0.82 | Inst Own | 101.54% | Short Float | 9.93% | Perf Quarter | -16.6% |
| Income | -0.20B | P/S | 31.44 | EPS this Y | 1.38% | Inst Trans | 1.15% | Short Ratio | 8.72 | Perf Half Y | -10.76% |
| Sales | 0.19B | P/B | 42.23 | EPS next 5Y | - | ROA | -44.94% | Short Interest | 6.32M | Perf YTD | -18.37% |
| Book/sh | 2.07 | P/C | 15.34 | EPS past 3/5Y | 3.66% -0.46% | ROE | -244.45% | 52W High | -28.49% ($122.20) | Perf Year | 73.93% |
| Cash/sh | 5.7 | P/FCF | - | Sales past 3/5Y | 100.23% - | ROIC | -53.95% | 52W Low | 90.35% ($45.90) | Perf 3Y | 357.25% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 28.7% | Gross Margin | 89.49% | Volatility(W/M) | 5.91% 5.71% | Perf 5Y | 234.92% |
| Dividend TTM | - | EV/Sales | 30.68 | Sales Y/Y TTM | 45.83% | Oper. Margin | -101.19% | ATR (14) | 5.41 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.16 | EPS Q/Q | -0.77% | Profit Margin | -106.41% | RSI (14) | 35.15 | Recom | 1.12 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.41 | Sales Q/Q | 36.87% | SMA20 | -8.25% ($95.24) | Beta | 2.15 | Target Price | $141 |
| Payout | - | Debt/Eq | 1.75 | Earnings | 2000000 | SMA50 | -13.03% ($100.47) | Rel Volume | 2.24 | Prev Close | $91.15 |
| Employees | 414 | LT Debt/Eq | 1.69 | EPS/Sales Surpr. | 9.26% 1.86% | SMA200 | -8.53% ($95.53) | Avg Volume(3M) | 0.72M | Price | $87.38 |
| IPO | 2017/10/5 | Option/Short | Yes/Yes | Trades | 17950 | Volume | 1,620,714 | Change | -4.14% |
뉴스 로딩 중...